M Nelles, V Salerno, Y Xu… - Experimental and Applied …, 2011 - Springer ... L ymphoma (III) · Colorectal carcinoma (III) · Ov arian carcinoma (II) · IV · SC · IT · IP · PEGylated recombinant protein · Autologous fibroblast/tumor cell v accine · Cell culture for adoptiv e transfer ... esical · Autologous fibroblast/DC/ tumor cell v accine · Plasmid electroporation ... Related articles - All 2 versions
BH Nelson… - Experimental and Applied Immunotherapy, 2011 - Springer ... Mutant KRAS P ancreatic cancer ( n = 48) Peptide v accine, intradermal Positiv e DTH and T -cell proliferation in 58% of patients Responding patients sho wed prolonged surviv al. ... V arious adv anced cancers ( n = 10) Peptide v accine, subcutaneous CD4 + and CD8 + T -cell ... Related articles - All 2 versions
P Hojman - Clinical Aspects of Electroporation, 2011 - Springer ... ery of a mouse tyrosinase plasmid DN A v accine in patients with stage IIB, IIC, III, or IV melanoma Biological: x enogeneic tyrosinase DN A v accine NCT00471133 Ichor medical systems incorporated Device: T riGrid deliv ery system HIV Infections ... Related articles - All 2 versions
JT Schiller… - History of Vaccine Development, 2011 - Springer ... Page 15. 279 Developmental History of HPV Prophylactic Vaccines T able 3 VLP v accine efficacy trials in young w omen: A TP analyses for v accine-specific HPV types in w omen neg ativ e for v accine type infections at enrollment Characteristic GSK 001/07 Merck 007 ... Related articles - All 2 versions
F Fenner - History of Vaccine Development, 2011 - Springer ... Page 5. 31 Smallpox Eradication: The Vindication of Jenner's Prophesy T able 1 WHO quality control of freeze-dried v accine: results of tests carried out in the WHO Reference Centres for Smallpox V accine in Biltho v en, the Netherlands and T ... Cited by 3 - Related articles - All 2 versions